Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin

Authors


Megan Keck, Pharmacy Coordinator, Pediatric Transplantation, Clinical Assistant Professor of Pharmacy, University of Nebraska Medical Center, 981090 Nebraska Medical Center, Omaha, NE 68198-1090, USA
Tel.: 402 559 5372
Fax: 402 559 4741
E-mail: mkeck@nebraskamed.com

Abstract

Keck M, Mindru C, Kalil AC, Mercer DF, Florescu DF. Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin.

Abstract:  The mainstay of therapy for RSV disease is supportive care, although aerosolized ribavirin has been used to treat infants and young children with severe lower respiratory tract infections. Aerosolized ribavirin has adverse effects, high cost and teratogenic potential. We report the case of a pediatric liver transplant recipient diagnosed with lower respiratory RSV infection, who was successfully treated with oral ribavirin.

Ancillary